These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7769818)

  • 1. Potentiating effect of nicorandil, an antianginal agent, on relaxation induced by isoproterenol in isolated rat aorta: involvement of cyclic GMP-inhibitable cyclic AMP phosphodiesterase.
    Satake N; Zhou Q; Morikawa M; Inoue M; Shibata S
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):489-94. PubMed ID: 7769818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
    Delpy E; Coste H; Gouville AC
    Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM; Kuo SC
    Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery.
    Zhou Q; Satake N; Shibata S
    Eur J Pharmacol; 1995 Jan; 273(1-2):153-9. PubMed ID: 7737309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD-832, a new dihydropyridine derivative with both nitrate-like and Ca2+ channel antagonist vasodilator activities.
    Miyata N; Yamaura H; Tanaka M; Takahashi K; Tsuchida K; Otomo S
    Eur J Pharmacol; 1993 Nov; 249(2):141-9. PubMed ID: 8287896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.
    Meisheri KD; Cipkus-Dubray LA; Hosner JM; Khan SA
    J Cardiovasc Pharmacol; 1991 Jun; 17(6):903-12. PubMed ID: 1714013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
    Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
    Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
    Fujiwara T; Angus JA
    Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E; le Monnier de Gouville AC
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.
    Kukovetz WR; Holzmann S; Braida C; Pöch G
    J Cardiovasc Pharmacol; 1991 Apr; 17(4):627-33. PubMed ID: 1711631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.
    Gray DW; Marshall I
    Br J Pharmacol; 1992 Nov; 107(3):684-90. PubMed ID: 1335334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors.
    Matsumoto T; Takahashi M; Omura T; Takaoka A; Liu Q; Nakae I; Kinoshita M
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):772-9. PubMed ID: 9234658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle.
    Yanagisawa T; Hashimoto H; Taira N
    Br J Pharmacol; 1988 Oct; 95(2):393-8. PubMed ID: 2852521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.
    Jinno Y; Kasai H; Ohta H; Nishikori K; Fukushima H; Ogawa N
    Br J Pharmacol; 1992 Aug; 106(4):906-9. PubMed ID: 1327392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potentiation of nitroglycerin-induced relaxation by PKG inhibition in rat aortic rings.
    Satake N; Fujimoto S; Shibata S
    Gen Pharmacol; 1996 Jun; 27(4):701-5. PubMed ID: 8853308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.